Scarica l'app Stockscreener
23.84
2.49%
-0.61
Dopo l'orario di chiusura:
23.84
Gh Research Plc Borsa (GHRS) Ultime notizie
GH Research PLC (1KA.HM) Stock Forum & Discussion - Yahoo! Finance Canada
GH Research PLC (1KA.HM) - Yahoo! Finance Canada
GH Research PLC (1KA.HM) Stock Price, News, Quote & History - Yahoo! Finance Canada
GH Research PLC (1KA.HM) balance sheet – Yahoo Finance - Yahoo Finance Singapore
GH Research PLC (1KA.HM) latest stock news and headlines – Yahoo Finance - Yahoo Finance Singapore
GH Research PLC (1KA.HM) valuation measures and financial statistics - Yahoo Finance Singapore
GH Research PLC (1KA.HM) company profile and factsYahoo Finance - Yahoo Finance Singapore
GH Research PLC (1KA.HM) income statement – Yahoo Finance - Yahoo Finance Singapore
GH Research PLC (1KA.HM) analyst ratings, estimates and forecasts – Yahoo Finance - Yahoo Finance Singapore
GH Research PLC (1KA.HM) stock historical prices and data - Yahoo Finance Singapore
GH Research PLC (1KA.HM) stock price, news, quote and history - Yahoo Finance Singapore
(GHRS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
GH Research gets FDA clearance to start phase 3 trial for new depression treatment in 2026 - pluang.com
GH Research: 'Buy' GH001 TRD Advancement Presses On And Expansion Opportunities - Seeking Alpha
GH Research PLC (GHRS): Investor Outlook on a Biotech Stock with a 49% Potential Upside - DirectorsTalk Interviews
GH Research PLC (NASDAQ: GHRS) Files September 2026 Report Under 1934 Exchange Act - kalkinemedia.com
GH Research PLC (GHRS) Stock Price Quote Today & Current Price Chart - Capital.com
GH Research Plans Investor Meetings at Morgan Stanley Global Healthcare Conference - TipRanks
$GHRS Q2 '26 Earnings Results & Recap - Stocktwits
GH Research (GHRS) plans one-on-one talks at 2026 Morgan Stanley healthcare event - Stock Titan
Price-Driven Insight from (GHRS) for Rule-Based Strategy - news.stocktradersdaily.com
GH Research (GHRS) director gets 2,303 options not exercisable until 2028 - Stock Titan
GH Research PLC (GHRS) Dips 1.56% as Shares Sit at Midpoint of Trading RangeEarnings Quality Factor - dars.gov.et
GHRS Q2 2026 Earnings: Loss Narrows More Than Expected as Investors Focus on PipelineEarnings Stability Report - dars.gov.et
(GHRS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
GH Research (GHRS) Slides 2.48% to $27.94 as Shares Approach Key SupportBearish Pattern Stocks - vinanet.vn
Net margin % of GH Research Plc – HAM:1KA - TradingView
Net income before discontinued operations of GH Research Plc – HAM:1KA - TradingView
GH Research Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
How Rising Losses And Milestone Spending At GH Research (GHRS) Have Changed Its Investment Story - simplywall.st
GHRS Q2 2026 Earnings: Narrower Loss of -$0.23 Per Share Beats Estimates by 25.6%Earnings Trend Analysis - vinanet.vn
Zacks Research Upgrades GH Research (NASDAQ:GHRS) to Hold - MarketBeat
GHRS Q2 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress Takes Center Stage - dars.gov.et
RA Capital discloses 7.1% GH Research PLC (GHRS) stake in Schedule 13G/A - Stock Titan
Lynx1 Capital Management (NASDAQ: GHRS) reports 19.3% stake in GH Research - Stock Titan
GH Research PLC (NASDAQ:GHRS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
GH Research PLC Director Duncan Moore Granted 2,202 Share Options - Kalkine Media
GH Research PLC (GHRS) director receives 2,202 fully vested share options - Stock Titan
GH Research PLC (GHRS) director receives 2,202 options at $0.025 strike - Stock Titan
GH Research PLC (GHRS) grants 102,202 share options to director Michael Forer - Stock Titan
GHRS Q2 2026 Earnings: Narrower-than-Expected Loss Delivers 25.6% EPS SurpriseFull Year Guidance - dars.gov.et
GH Research (NASDAQ:GHRS) Sees Strong Trading VolumeShould You Buy? - MarketBeat
FY2026 EPS Estimates for GH Research Boosted by Analyst - MarketBeat
GH Research (GHRS) Retreats 2.4% to $29.53 as Clinical-Stage Biotech ConsolidatesTechnical Analysis - siam.in
Trading the Move, Not the Narrative: (GHRS) Edition - Stock Traders Daily
H.C. Wainwright reiterates GH Research stock rating on FDA progress By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates GH Research stock rating on FDA progress - Investing.com
Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative? - simplywall.st
GH Research (NASDAQ:GHRS) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
GH Research (NASDAQ:GHRS) Upgraded at Wall Street Zen - MarketBeat
GH Research stock hits all-time high at 31.41 USD By Investing.com - Investing.com India
GH Research (NASDAQ:GHRS) Reaches New 12-Month High Following Earnings Beat - marketbeat.com
GH Research stock hits all-time high at 31.41 USD - Investing.com
GH Research (NASDAQ:GHRS) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
GH Research PLC (GHRS) Stock Analysis: A Biotech Powerhouse with 30.55% Upside Potential - DirectorsTalk Interviews
GH Research PLC (GHRS) Stock News Today - TradingKey
GH Research PLC (GHRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GH Research (GHRS) Dips 1.21% to $30.27 Amid Clinical-Stage Biotech CautionVolatility Term Structure - careplusvn.com
GH Research PLC Stock 12‑Month Price Target Raised to $41.1, Implies 41% Upside - TradingView
Needham & Company LLC Raises GH Research (NASDAQ:GHRS) Price Target to $39.00 - MarketBeat
GH Research PLC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):